Characterization of biosynthetic and self-protection mechanisms on novel bacteriocin produced by plant-derived LAB strain 174A
| Project/Area Number |
22790069
|
|---|
| Research Category |
Grant-in-Aid for Young Scientists (B)
|
| Allocation Type | Single-year Grants |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Hiroshima University |
|---|
Principal Investigator |
NODA Masafumi 広島大学, 大学院・医歯薬保健学研究院, 特任講師 (40457289)
|
|---|
| Project Period (FY) |
2010 – 2012
|
| Project Status |
Completed (Fiscal Year 2012)
|
| Budget Amount *help |
¥4,030,000 (Direct Cost: ¥3,100,000、Indirect Cost: ¥930,000)
Fiscal Year 2012: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2011: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2010: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
|
|---|
| Keywords | 微生物 / 発現制御 / バイオテクノロジー |
|---|
| Research Abstract |
Brevicin 174A is classified into the class IIb bacteriocin, and is composed of two peptides, named brevicin 174A-βand 174A-γ. In the present study, the presumed target protein for brevicin 174A was found in the membrane fraction from brevicin 174A-sensitive lactic acid bacteria.
|
Report
(4 results)
Research Products
(11 results)
